Embremma 0.5 mg Injection
$220,99
$172,37
Embremma 0.5 mg Injection is a targeted anticancer therapy designed specifically for patients battling metastatic breast cancer who have undergone at least two prior chemotherapy treatments. Additionally, this medication is effective for individuals with unresectable liposarcoma who have previously received anthracycline-based therapies for advanced or metastatic conditions, provided they are suitable candidates. By inhibiting the growth and dissemination of cancer cells, Embremma plays a critical role in managing these challenging malignancies. It’s important to note that this injection should only be administered under the supervision of a qualified healthcare professional due to potential side effects and specific contraindications. Patients are advised to discuss their medical history and any ongoing treatments with their doctor to ensure safe and effective use. With its unique mechanism of action, Embremma 0.5 mg Injection represents a vital option in the complex landscape of cancer care. Always consult your healthcare provider for personalized advice and treatment plans tailored to your individual needs.
數量
Active Pharmaceutical Ingredient
Uses
• Embremma 0.5 mg injection is primarily indicated for the treatment of metastatic breast cancer. This condition occurs when cancer cells spread from the breast to other parts of the body, such as bones or lungs. By using Embremma 0.5 mg injection, healthcare providers aim to alleviate symptoms and improve the quality of life for patients. It can help manage pain and discomfort associated with the spread of cancer.
• Patients experiencing symptoms like swelling, shortness of breath, or persistent cough may benefit from Embremma 0.5 mg injection. This medication can help reduce these symptoms, providing relief to those affected by metastatic breast cancer. It works by targeting cancerous cells, thus potentially decreasing the burden of these distressing symptoms. The goal is to enhance the overall well-being of patients during treatment.
• In cases of metastatic breast cancer, Embremma 0.5 mg injection is often used as part of a comprehensive treatment plan. This medication may be administered alongside other therapies to optimize patient outcomes. By incorporating Embremma 0.5 mg injection, healthcare professionals strive to manage the disease more effectively. Patients may find that their appetite and energy levels improve as a result of this treatment.
• Embremma 0.5 mg injection plays a crucial role in the management of metastatic breast cancer, particularly for patients with significant discomfort. It helps address the physical challenges that arise from the disease's progression. With the administration of Embremma 0.5 mg injection, healthcare providers can focus on alleviating symptoms and improving daily functioning. This approach is vital for supporting patients through their treatment journey.
Benefits
Metastatic breast cancer is a type of advanced breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain. Embremma 0.5 mg Injection is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Embremma 0.5 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Soft tissue sarcoma (Liposarcoma): soft tissue sarcoma is a group of cancers that develop in the soft tissues of the body, such as the muscles, fat, nerves, blood vessels, and connective tissues. This medicine is used who have received prior anthracycline-containing therapy and have not shown significant improvement. Embremma 0.5 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Embremma 0.5 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Breathlessness
• Risk of Infection
• Loss of appetite
• Headaches
• Numbness or tingling in toes and fingers
• Cough
• Feeling sick
• Diarrhoea
• Constipation
• Hair loss
• Body Pain
• Fever
• Fatigue
• Weight loss
Common Side Effects
• Sepsis
• Blood clot in veins
• Inflammation of the pancreas
• Liver Damage
• Protein and blood in your urine
• Severe skin reaction
• Bruising and bleeding
• Changes in heartbeat
How To Use
Embremma 0.5 mg is given intravenously (in vein) or as an intravenous infusion over 2 to 5 minutes by a healthcare professional, doctor or nurse in a hospital. The dosage and frequency of Embremma 0.5 mg depend on various factors, including your weight and height, your health problems and what type of cancer and condition you have. Your health professional may decrease your dose or delay your treatment if you experience serious side effects. While during the treatment closely monitor the patient while blood cell count, peripheral neuropathy signs and symptoms.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Embremma 0.5 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Embremma 0.5 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Embremma 0.5 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Embremma 0.5 mg. Embremma 0.5 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Embremma 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Embremma 0.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Embremma 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Embremma 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Embremma 0.5 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Embremma 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Embremma 0.5 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Embremma 0.5 mg.